Navigation Links
DePuy ASR Lawsuit Update: Parker Waichman LLP Commends Judge’s Refusal of Appeal for New Trial; DePuy Still Must Pay $8.3 Million Verdict
Date:5/28/2013

New York, New York (PRWEB) May 28, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, applauds the judge’s decision to uphold the jury verdict that concluded the first lawsuit of more than 10,000 to reach trial over DePuy’s recalled ASR metal-on-metal hip implants. As reported by MassDevice on May 27, 2013, California Judge J. Stephen Czuleger rejected DePuy's bid for a new trial and let the verdict stand; the jury, having decreed that DePuy’s all-metal implants were defectively designed, had awarded Plaintiff Loren Kransky $8.3 million, in the case of Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County (Los Angeles).

“The judge’s decision to uphold the verdict in favor of the Plaintiff is a reassuring victory for thousands of individuals who allege that the DePuy ASR hip implant has caused them injuries,” said Daniel C. Burke, Senior Litigation Counsel at Parker Waichman LLP. “The jury’s decision sent a clear message to Johnson & Johnson that it cannot get away with harming patients; the judge maintaining that verdict almost serves to underscore the message.”

Parker Waichman LLP continues to offer free legal advice to patients who have implants devices such as DePuy’ all-metal hip, and advises them to speak with their doctors if they experience symptoms such as:

  •         Pain
  •         Swelling
  •         Difficulty walking, or a change in your ability to walk
  •         Metallosis, high levels of metal ions in the bloodstream
  •         Early failure, revision surgery

On March 8, 2013, Bloomberg reported that the jury’s verdict came on the sixth day of deliberations, ruling that DePuy Orthopaedics and parent company Johnson & Johnson were negligent with regards to Kransky’s ASR hip implant; the verdict included $338,136 for medical expenses and $8 million for pain and suffering. According to Bloomberg, David Vega, who was one of the jurors in the trial, said “I wanted punitive damages” because J&J was slow to correct problems with the recalled hip implant.

The Bloomberg article added that Johnson & Johnson recalled 93,000 ASR hips in 2010, citing a failure rate of 12 percent in five years. In Australia, failure rates have exceeded 40 percent in seven years, Bloomberg reported. Kransky’s lawsuit alleged that the defects of the metal-on-metal hip implant caused severe complications, including metal poisoning, that forced him to undergo revision surgery. During the trial, the Plaintiffs alleged that DePuy failed to properly test the hip replacement and that the company ignored complaints from surgeons who reported high failure rates prior to the recall.

The DePuy ASR and other metal-on-metal hip implants were approved without clinical testing for safety or efficacy due to the 510(k) approval route, which exempts devices from clinical testing as long as the manufacturers show that their product is similar to a previous device. The U.S. Food and Drug Administration (FDA) reported on Jan. 18, 2013, that it was attempting to change the 510(k) approval process; the agency has proposed that all-metal hip replacements go through premarket approval, which would require device makers to prove that their products are safe and effective.

Parker Waichman LLP continues to offer free legal consultations to victims of DePuy ASR and other metal-on-metal hip implant injuries. If you or a loved one experienced premature failure of your implant or other health problems associated with a recalled DePuy ASR Hip Implant or other metal-on-metal hip implant, please contact their office by visiting the firm's DePuy ASR hip implant injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
yourlawyer.com

Read the full story at http://www.prweb.com/releases/DePuyASR_verdict_upheld/05/prweb10776487.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy ASR Hip Lawsuit Update: Rottenstein Law Group LLP Comments on Upheld $8.3 Million ASR Verdict
2. DePuy ASR Hip Lawsuit Judge Upholds $8.3 Million Verdict in Nation’s First Trial Stemming from 2010 DePuy ASR Recall, Bernstein Liebhard LLP Reports
3. DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case
4. DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation
5. DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants, Notes Rottenstein Law Group LLP
6. Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products
7. DePuy Pinnacle Hip Implant Lawsuit News: Bernstein Liebhard LLP Comments on Johnson & Johnson Decision to Stop Metal-on-Metal Hip Sales
8. DePuy ASR Lawsuit Update: Rottenstein Law Group Comments on Delay of Second Federal Trial
9. DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Rescheduling of First Bellwether Trial in Federal DePuy ASR Litigation
10. Alleged DePuy Knee Sleeve Failure Lawsuits Now Being Reviewed by Resource4thePeople Attorneys
11. DePuy ASR Lawsuit Update: Rottenstein Law Group Addresses J&J Motion to Appeal $8.3 Million Verdict
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... The ... candidates for the Board of Commissioners. Individuals interested in volunteer board service are ... diversity of clinical practice settings and across allied health to contribute to its ...
(Date:2/11/2016)... SURPRISE, ARIZ. (PRWEB) , ... February 11, 2016 , ... ... kids,” a group of men, 60 and older, who gather once a year to ... , Besides a love for the game, the more than 50 players who competed ...
(Date:2/11/2016)... ... February 11, 2016 , ... AccuVein Inc. ... Infusion Therapy Standards of Practice, to include vascular visualization as a standard practice. ... 85% share of the market, facilitates adherence to this standard with its easy ...
(Date:2/11/2016)... ... February 11, 2016 , ... Dickinson Insurance & Financial Services ... a new fundraiser in support of a local boy named Barrett, who has been ... bring awareness to, and rally support for, all local families dealing with childhood cancer. ...
(Date:2/11/2016)... ... ... Be Well Medical Group (Be Well) is pleased to announce the ... Columbus St, Suite 201, Alexandria, VA. Be Well Medical Group is a concierge practice ... their homes, offices or at the practices’ local office. It is also one of ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 11, 2016 ... of the "Molecular Diagnostics Reports Bundle" ... http://www.researchandmarkets.com/research/rp4pg8/molecular ) has announced the addition ... report to their offering. --> ... has announced the addition of the ...
(Date:2/10/2016)... REDWOOD CITY, Calif., Feb. 10, 2016   Genomic Health, Inc. ... progress for the quarter and year ended December 31, 2015. ... in the fourth quarter of 2015, compared with $69.1 million in ... a constant currency basis, revenue increased 9 percent compared with the ... --> U.S. revenue was $63.9 million in the fourth ...
(Date:2/10/2016)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), ... quarter and full year ended December 31, 2015. ... a transformational year for Vanda with the continued growth ... approval of HETLIOZ for Non-24," said Mihael H. Polymeropoulos, ... to our U.S. product portfolio builds on this success ...
Breaking Medicine Technology: